Connection

Edwin Naylor to Infant, Newborn

This is a "connection" page, showing publications Edwin Naylor has written about Infant, Newborn.
Connection Strength

0.690
  1. Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing. Genet Med. 2015 May; 17(5):337-47.
    View in: PubMed
    Score: 0.076
  2. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab. 2005 Sep-Oct; 86(1-2):212-9.
    View in: PubMed
    Score: 0.040
  3. A high throughput beta-globin genotyping method by multiplexed melting temperature analysis. Mol Genet Metab. 2004 Mar; 81(3):237-43.
    View in: PubMed
    Score: 0.037
  4. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clin Chem. 2003 Nov; 49(11):1797-817.
    View in: PubMed
    Score: 0.036
  5. Analysis of common mutations in the galactose-1-phosphate uridyl transferase gene: new assays to increase the sensitivity and specificity of newborn screening for galactosemia. J Mol Diagn. 2003 Feb; 5(1):42-7.
    View in: PubMed
    Score: 0.034
  6. Real time PCR assays to detect common mutations in the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency. Mol Genet Metab. 2003 Feb; 78(2):100-7.
    View in: PubMed
    Score: 0.034
  7. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annu Rev Genomics Hum Genet. 2002; 3:17-45.
    View in: PubMed
    Score: 0.032
  8. Newborn screening for urea cycle disorders. Adv Exp Med Biol. 1982; 153:9-18.
    View in: PubMed
    Score: 0.032
  9. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem. 2001; 47(7):1166-82.
    View in: PubMed
    Score: 0.030
  10. Laboratory integration and utilization of tandem mass spectrometry in neonatal screening: a model for clinical mass spectrometry in the next millennium. Acta Paediatr Suppl. 1999 Dec; 88(432):45-7.
    View in: PubMed
    Score: 0.027
  11. Molecular analysis using targeted next generation DNA sequencing and clinical spectrum of Mexican patients with isovaleric acidemia. Clin Chim Acta. 2020 Feb; 501:216-221.
    View in: PubMed
    Score: 0.027
  12. Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem. 1997 Nov; 43(11):2106-13.
    View in: PubMed
    Score: 0.024
  13. Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry. Am J Med Genet. 1997 Jan 31; 68(3):300-4.
    View in: PubMed
    Score: 0.022
  14. Twenty-year follow-up of newborn screening for patients with muscular dystrophy. Muscle Nerve. 2016 Apr; 53(4):570-8.
    View in: PubMed
    Score: 0.020
  15. Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res. 1995 May; 37(5):675-8.
    View in: PubMed
    Score: 0.020
  16. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin Chem. 1995 Jan; 41(1):62-8.
    View in: PubMed
    Score: 0.019
  17. Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy. Muscle Nerve. 2014 Jun; 49(6):822-8.
    View in: PubMed
    Score: 0.019
  18. Neonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity. Biochem Med Metab Biol. 1993 Apr; 49(2):200-11.
    View in: PubMed
    Score: 0.017
  19. Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling. Clin Chem. 2012 Jun; 58(6):1033-9.
    View in: PubMed
    Score: 0.016
  20. New technologies in newborn screening. Yale J Biol Med. 1991 Jan-Feb; 64(1):21-4.
    View in: PubMed
    Score: 0.015
  21. Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening. Mol Genet Metab. 2010 Sep; 101(1):33-9.
    View in: PubMed
    Score: 0.014
  22. Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients. J Inherit Metab Dis. 2009 Feb; 32(1):10-21.
    View in: PubMed
    Score: 0.013
  23. Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles. Mol Genet Metab. 2007 Jul; 91(3):218-27.
    View in: PubMed
    Score: 0.011
  24. Recent developments in neonatal screening. Semin Perinatol. 1985 Apr; 9(3):232-49.
    View in: PubMed
    Score: 0.010
  25. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003 Nov 19; 290(19):2564-72.
    View in: PubMed
    Score: 0.009
  26. Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectometry. Pediatr Res. 2003 May; 53(5):823-9.
    View in: PubMed
    Score: 0.009
  27. Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet. 2001 Jun; 68(6):1408-18.
    View in: PubMed
    Score: 0.008
  28. DNA microarray technology for neonatal screening. Acta Paediatr Suppl. 1999 Dec; 88(432):61-4.
    View in: PubMed
    Score: 0.007
  29. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol. 1999 Nov; 14 Suppl 1:S4-8.
    View in: PubMed
    Score: 0.007
  30. 3-Methylcrotonyl-coenzyme A carboxylase deficiency in Amish/Mennonite adults identified by detection of increased acylcarnitines in blood spots of their children. J Pediatr. 1998 Mar; 132(3 Pt 1):519-23.
    View in: PubMed
    Score: 0.006
  31. Molecular diagnosis of cystic fibrosis. Clin Lab Med. 1995 Dec; 15(4):877-98.
    View in: PubMed
    Score: 0.005
  32. A neonatal screening test for argininosuccinic acid lyase deficiency and other urea cycle disorders. Pediatrics. 1982 Oct; 70(4):526-31.
    View in: PubMed
    Score: 0.002
  33. Screening test for alpha 1-antitrypsin in dried-blood specimens. Clin Chem. 1982 Apr; 28(4 Pt 1):615-7.
    View in: PubMed
    Score: 0.002
  34. Neonatal urine screening for metabolic disease with auxotrophic strains of Bacillus subtilis. Clin Chim Acta. 1982 Mar 12; 119(3):345-9.
    View in: PubMed
    Score: 0.002
  35. A simple screening test for reduced glutathione in filter paper spots of blood. J Pediatr. 1981 Feb; 98(2):265-7.
    View in: PubMed
    Score: 0.002
  36. Fluorometric micromethod for determination of arginase activity in dried blood spots on filter paper. Clin Chem. 1980 Jul; 26(8):1198-200.
    View in: PubMed
    Score: 0.002
  37. Ultramicromethod for estimation of total glutathione in dried blood spots on filter paper. Anal Biochem. 1980 May 01; 104(1):70-4.
    View in: PubMed
    Score: 0.002
  38. Micromethod for estimating adenosine deaminase activity in dried blood spots on filter paper. Clin Chem. 1978 Apr; 24(4):591-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.